EUVIMEDEUVIMED entdecken
Crossref

Cardiac index: A superior parameter of cardiac function than left ventricular ejection fraction in risk stratification of hypertrophic cardiomyopathy

Yu Zhang, Yuming Zhu, Dong Wang, Lianjun Xu, Wen Jiang, Jizheng Wang, Xiaolu Sun, Lianming Kang, Lei Song

Heart Rhythm · 2023

DOI: 10.1016/j.hrthm.2023.02.028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Heart Rhythm, 2023. Verfasst von Yu Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and …. Hauptthemen laut MEDLINE: Ventricular Function, Left, Cardiomyopathy, Hypertrophic. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Chinese Academy of Meteorological Sciences, Heilongjiang Provincial Science and Technology Department.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: An appropriate indicator of cardiac function in the risk stratification of hypertrophic cardiomyopathy (HCM) patients is urgently needed. Cardiac index that reflects cardiac pumping function may be suitable. OBJECTIVE: The purpose of this study was to investigate the clinical significance of reduced cardiac index in HCM patients. METHODS: A total of 927 HCM patients were enrolled. The primary endpoint was cardiovascular death. The secondary endpoints were sudden cardiac death (SCD) and all-cause death. Combination models were constructed by adding reduced cardiac index and reduced left ventricular ejection fraction (LVEF) to the HCM risk-SCD model. Predictive accuracy was determined by C-statistics. RESULTS: Reduced cardiac index was defined as cardiac index ≤2.42 L/min/m2. During median follow-up of 4.3 years, 51 patients reached the endpoint. Reduced cardiac index independently increased the risk of cardiovascular death (adjusted hazard ratio [aHR] 2.976; P = .007), SCD (aHR 6.385; P = .001), and all-cause death (aHR 2.428; P = .010). By adding reduced cardiac index to the HCM risk-SCD model, the model C-statistic increased from 0.691 to 0.762, with an integrated discrimination improvement of 0.021 (P = .018) and a net reclassification improvement of 0.560 (P = .007). The addition of reduced LVEF failed to improve the original model. Better predictive accuracy for all endpoints was also indicated in reduced cardiac index than in reduced LVEF. CONCLUSION: Reduced cardiac index is an independent predictor of poor prognoses in HCM patients. Combining reduced cardiac index rather than reduced LVEF improved the HCM risk-SCD stratification strategy. The reduced cardiac index showed better predictive accuracy than reduced LVEF for all endpoints.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ventricular Function, LeftCardiomyopathy, HypertrophicHumansStroke VolumeRisk FactorsPrognosisDeath, Sudden, CardiacRisk Assessment

Stichwörter der Autor:innen

Cardiac indexHypertrophic cardiomyopathyLeft ventricular ejection fractionRisk stratificationSudden cardiac death

Autor:innen und Institutionen

  • State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Cardiomyopathy Ward, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Cardiomyopathy Ward, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. Electronic address: fwxiaolusun@yahoo.com.
  • Cardiomyopathy Ward, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. Electronic address: lianmingkang@126.com.
  • State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; Cardiomyopathy Ward, Fuw…

Förderung

  • National Natural Science Foundation of China
  • Chinese Academy of Meteorological Sciences
  • Heilongjiang Provincial Science and Technology Department
  • CAMS Innovation Fund for Medical Sciences

Zitieren

APA

Zhang, Y., Zhu, Y., Wang, D., Xu, L., Jiang, W., Wang, J., Sun, X., Kang, L., & Song, L. (2023). Cardiac index: A superior parameter of cardiac function than left ventricular ejection fraction in risk stratification of hypertrophic cardiomyopathy. Heart Rhythm. https://doi.org/10.1016/j.hrthm.2023.02.028

Vancouver

Zhang Y, Zhu Y, Wang D, Xu L, Jiang W, Wang J, et al. Cardiac index: A superior parameter of cardiac function than left ventricular ejection fraction in risk stratification of hypertrophic cardiomyopathy. Heart Rhythm. 2023. doi:10.1016/j.hrthm.2023.02.028

BibTeX
@article{Zhang2023,
  author = {Zhang, Yu and Zhu, Yuming and Wang, Dong and Xu, Lianjun and Jiang, Wen and Wang, Jizheng and Sun, Xiaolu and Kang, Lianming and Song, Lei},
  title = {Cardiac index: A superior parameter of cardiac function than left ventricular ejection fraction in risk stratification of hypertrophic cardiomyopathy},
  journal = {Heart Rhythm},
  year = {2023},
  doi = {10.1016/j.hrthm.2023.02.028}
}
Kostenlos starten →